What is REGIONAL HEALTH PRP PFD A's earnings per share (EPS)?

REGIONAL HEALTH PRP PFD A (RHEPA) reported diluted earnings per share of $1.09 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

REGIONAL HEALTH PRP PFD A (RHEPA) Financials

RHEPA

Trailing 12 months to June 30, 2026

Revenue $81.5M +200.5% YoY

Net Income $4.1M +195.5% YoY

EPS (Diluted) $1.63 YoY not available

Free Cash Flow -$3.9M -442.2% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 12, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RHEPA SEC filings page.

REGIONAL HEALTH PRP PFD A (RHEPA) reported $81.5M in revenue over the twelve months to Jun 30, 2026, up 200.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RHEPA FY2025 2026-08-29

Revenue expansion produced accounting profit, but cash conversion and balance-sheet capacity remained constrained.

FY2025’s revenue expansion to $53.2M did not become operating cash, as operating cash flow was -$2.3M. That gap with net income of $3.4M indicates earnings were not translating into cash during the period, while a $15.1M investing inflow and $10.3M financing outflow materially shaped cash activity outside operations.

The reported gross margin of 86.9% coexisted with an operating margin of 3.1%. With SG&A at $12.0M, most gross profit was consumed before operations reached the bottom line, making overhead burden more important than product cost in explaining profitability.

The capital structure remains extremely thin: liabilities were $62.8M against only $349K of equity. A debt-to-equity ratio of 99.5x and a current ratio of 0.7x show both long-term leverage and short-term obligations remain central constraints on the business.

Financial Health Signals

Financial health score not available

REGIONAL HEALTH PRP PFD A does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/8

REGIONAL HEALTH PRP PFD A passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

$0.67used

For every $1 of reported earnings, REGIONAL HEALTH PRP PFD A used $0.67 of operating cash (-$2.3M OCF vs $3.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage At Risk

0.62x

REGIONAL HEALTH PRP PFD A earns $0.62 in operating income for every $1 of interest expense ($1.7M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$24.4M

YoY+143.0%

QoQ+15.5%

5Y CAGR+30.5%

10Y CAGR+13.1%

REGIONAL HEALTH PRP PFD A generated $24.4M in revenue in Q2 2026. This represents an increase of 143.0% from the same quarter a year earlier. Against the prior quarter it is up 15.5%.

EBITDA

$541K

YoY+615.2%

QoQ+2605.0%

5Y CAGR-13.8%

10Y CAGR-11.8%

REGIONAL HEALTH PRP PFD A's EBITDA was $541K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 615.2% from the same quarter a year earlier. Against the prior quarter it is up 2605.0%.

Net Income

-$791K

YoY+45.4%

QoQ+35.2%

REGIONAL HEALTH PRP PFD A reported -$791K in net income in Q2 2026. This represents an increase of 45.4% from the same quarter a year earlier. Against the prior quarter it is up 35.2%.

EPS (Diluted)

-$0.20

QoQ+31.0%

REGIONAL HEALTH PRP PFD A earned -$0.20 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 31.0%.

Cash & Balance Sheet

Free Cash Flow

$889K

YoY+224.5%

QoQ+170.9%

10Y CAGR-5.7%

REGIONAL HEALTH PRP PFD A generated $889K in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 224.5% from the same quarter a year earlier. Against the prior quarter it is up 170.9%.

Cash & Debt

$1.7M

YoY+325.0%

QoQ+54.5%

5Y CAGR-21.2%

10Y CAGR-6.3%

REGIONAL HEALTH PRP PFD A held $1.7M in cash against $34.1M in long-term debt as of Q2 2026.

Shares Outstanding

QoQ0.0%

5Y CAGR+17.8%

10Y CAGR-15.0%

REGIONAL HEALTH PRP PFD A had 4M shares outstanding in Q2 2026. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

75.1%

QoQ-3.7pp

REGIONAL HEALTH PRP PFD A's gross margin was 75.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is down 3.7 percentage points.

Operating Margin

-0.9%

YoY+4.2pp

QoQ+2.4pp

5Y change-8.4pp

10Y change-8.6pp

REGIONAL HEALTH PRP PFD A's operating margin was -0.9% in Q2 2026, reflecting core business profitability. This is up 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Net Margin

-3.2%

YoY+11.2pp

QoQ+2.5pp

5Y change+4.5pp

10Y change+66.3pp

REGIONAL HEALTH PRP PFD A's net profit margin was -3.2% in Q2 2026, showing the share of revenue converted to profit. This is up 11.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$498K

YoY+68.8%

QoQ+36.8%

5Y CAGR+64.8%

10Y CAGR+34.9%

REGIONAL HEALTH PRP PFD A invested $498K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 68.8% from the same quarter a year earlier. Against the prior quarter it is up 36.8%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

RHEPA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RHEPA quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$81.5M	$53.2M+189.9%	$18.3M+6.8%	$17.2M-52.2%	$35.9M+34.6%	$26.7M+51.8%	$17.6M-12.7%	$20.1M-8.7%	$22.0M-12.3%	$25.1M-8.9%	$27.6M+50.0%	$18.4M+453.4%	$3.3M-98.2%	$185.8M-4.3%	$194.1M+40.4%	$138.2M
Cost of Revenue	N/A	$7.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$46.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$20.6M	$12.0M+122.7%	$5.4M-0.1%	$5.4M+16.3%	$4.7M+18.3%	$3.9M+16.5%	$3.4M+5.7%	$3.2M-13.5%	$3.7M-4.2%	$3.9M-50.0%	$7.7M-26.8%	$10.5M-32.8%	$15.7M-17.5%	$19.0M+11.9%	$17.0M+28.0%	$13.3M
Operating Income	$1.6M	$1.7M+933.5%	$161K+119.6%	-$821K+88.0%	-$6.8M-369.3%	$2.5M+10.4%	$2.3M-58.0%	$5.5M+789.6%	-$792K-115.4%	$5.1M+13.7%	$4.5M+159.1%	-$7.6M+68.4%	-$24.2M-1383.6%	-$1.6M-159.9%	$2.7M+145.5%	$1.1M
EBITDA	N/A	$3.7M+67.7%	$2.2M+55.0%	$1.4M+132.5%	-$4.4M-186.2%	$5.1M-1.2%	$5.2M-41.7%	$8.9M+131.7%	$3.8M-61.6%	$10.0M+1.9%	$9.8M+3415.9%	-$296K+98.2%	-$16.8M-417.9%	$5.3M-42.9%	$9.3M+107.3%	$4.5M
Interest Expense	$2.5M	$2.7M-1.4%	$2.7M-1.5%	$2.8M+8.8%	$2.5M-5.2%	$2.7M-3.9%	$2.8M-47.3%	$5.3M-11.2%	$5.9M+44.8%	$4.1M-42.7%	$7.1M-15.5%	$8.5M-20.7%	$10.7M-13.6%	$12.4M-2.6%	$12.7M+71.9%	$7.4M
Income Tax	N/A	$108K	N/A	N/A	N/A	N/A	N/A	$0+100.0%	-$38K+79.8%	-$188K-15.3%	-$163K-248.2%	$110K-16.0%	$131K-7.7%	$142K+46.4%	$97K-54.9%	$215K
Net Income	$4.1M	$3.4M+204.7%	-$3.2M+17.2%	-$3.9M+43.4%	-$6.9M-481.0%	-$1.2M-71.8%	-$688K-112.5%	$5.5M+146.2%	-$11.9M-1107.6%	-$985K+86.8%	-$7.5M+68.3%	-$23.5M-72.9%	-$13.6M-8.2%	-$12.6M-82.6%	-$6.9M-11.7%	-$6.2M
EPS (Basic)	N/A	$1.09+163.0%	-$1.73-108.2%	$21.05+335.7%	-$8.93-52.1%	-$5.87	N/A	N/A	N/A	N/A	-$0.74+49.3%	-$1.46-62.2%	-$0.90+4.3%	-$0.94-88.0%	-$0.50+15.3%	-$0.59
EPS (Diluted)	$1.63	$1.09	-$1.73-108.2%	$21.05+335.7%	-$8.93	-$5.87	N/A	N/A	N/A	N/A	-$0.74	-$1.46-62.2%	-$0.90+4.3%	-$0.94-88.0%	-$0.50+15.3%	-$0.59
Diluted Shares (Avg)	N/A	2,805	1,858-1.0%	1,877-99.9%	2M	2M	N/A	N/A	N/A	N/A	20M	20M+9.8%	18M+19.2%	15M+7.2%	14M+33.8%	10M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$24.4M+143.0%	$21.2M+194.3%	$20.8M+267.2%	$15.1M+258.3%	$10.1M+132.5%	$7.2M+74.2%	$5.7M+25.1%	$4.2M+2.1%
Cost of Revenue	$6.1M	$4.5M	N/A	$2.5M	N/A	N/A	N/A	N/A
Gross Profit	$18.4M	$16.7M	N/A	$12.7M	N/A	N/A	N/A	N/A
SG&A Expenses	$6.7M+175.7%	$6.5M+192.2%	$3.7M+177.2%	$3.7M+203.3%	$2.4M+97.6%	$2.2M+36.7%	$1.3M+17.1%	$1.2M-7.9%
Operating Income	-$216K+57.5%	-$702K-120.8%	$3.1M+470.1%	-$594K-98.0%	-$508K-337.4%	-$318K-8.2%	$541K+240.3%	-$300K+25.7%
EBITDA	$541K+615.2%	$20K-76.2%	$3.8M+243.8%	-$47K-127.0%	-$105K-114.4%	$84K-61.3%	$1.1M+63.3%	$174K+42.6%
Interest Expense	$567K-7.8%	$522K-20.1%	$652K-5.5%	$751K+10.9%	$615K-8.1%	$653K-3.1%	$690K+0.9%	$677K-4.4%
Net Income	-$791K+45.4%	-$1.2M+3.2%	$2.7M+575.2%	$3.4M+444.4%	-$1.4M-105.2%	-$1.3M-31.2%	-$568K-138.7%	-$982K-0.9%
EPS (Basic)	-$0.20+70.6%	-$0.29+69.1%	$0.95+406.5%	$1.17+325.0%	-$0.68-78.9%	-$0.94-80.8%	-$0.31-138.5%	-$0.520.0%
EPS (Diluted)	-$0.20	-$0.29	$0.95	$1.17	-$0.68-78.9%	-$0.94-80.8%	-$0.31-138.5%	-$0.520.0%
Diluted Shares (Avg)	4M	4M	N/A	3,125	2M+115926.0%	2M+8.4%	N/A	1,904-99.9%

Not reported in any period shown, so not listed: R&D Expenses, Income Tax.

RHEPA Balance Sheet

RHEPA quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$67.8M+12.1%	$60.5M-2.8%	$62.2M-9.3%	$68.6M-35.1%	$105.7M-2.2%	$108.0M-5.0%	$113.8M+13.1%	$100.6M-5.6%	$106.6M-10.8%	$119.5M-29.4%	$169.3M-19.4%	$210.0M-7.3%	$226.4M-3.7%	$235.2M+47.9%	$159.1M
Current Assets	$16.3M+138.8%	$6.8M	N/A	N/A	N/A	N/A	$7.4M-8.4%	$8.1M+71.7%	$4.7M-77.0%	$20.5M-18.6%	$25.2M-55.9%	$57.0M-3.0%	$58.7M+13.1%	$51.9M+80.7%	$28.7M
Cash & Equivalents	$3.0M+415.5%	$582K-41.8%	$1.0M+25.0%	$800K-88.2%	$6.8M+61.9%	$4.2M-4.5%	$4.4M+83.3%	$2.4M+32.0%	$1.8M-87.1%	$14.0M+416.4%	$2.7M-74.7%	$10.7M-44.6%	$19.4M+21.6%	$15.9M+116.4%	$7.4M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$8.0M+138.7%	$3.4M+140.1%	$1.4M-77.7%	$6.3M+193.2%	$2.1M+2.1%	$2.1M+110.0%	$1.0M0.0%	$1.0M+5.8%	$945K-61.1%	$2.4M-72.4%	$8.8M-63.8%	$24.3M+2.9%	$23.6M-12.1%	$26.8M+42.9%	$18.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M-24.7%	$2.1M0.0%	$2.1M0.0%	$2.1M-49.7%	$4.2M-1.0%	$4.2M0.0%	$4.2M-15.9%	$5.0M+39.5%	$3.6M
Total Liabilities	$62.8M-1.0%	$63.4M+2.2%	$62.0M-4.4%	$64.9M-31.9%	$95.3M-1.7%	$96.9M-5.0%	$102.0M+8.0%	$94.4M+6.5%	$88.7M-43.7%	$157.4M-18.5%	$193.1M+3.7%	$186.2M-6.5%	$199.1M-5.6%	$211.0M+46.9%	$143.6M
Current Liabilities	$24.2M+18.4%	$20.4M	N/A	N/A	N/A	N/A	$14.1M-61.6%	$36.7M+88.3%	$19.5M-22.8%	$25.3M-60.4%	$63.8M-7.9%	$69.3M+0.1%	$69.2M+21.3%	$57.1M+67.4%	$34.1M
Non-Current Liabilities	$38.6M-10.1%	$43.0M	N/A	N/A	N/A	N/A	$87.9M+52.3%	$57.7M-16.6%	$69.2M-47.7%	$132.2M+2.2%	$129.3M+10.6%	$116.9M-10.0%	$129.9M-15.6%	$154.0M+40.6%	$109.5M
Long-Term Debt	$34.7M-11.6%	$39.3M-22.6%	$50.7M-2.8%	$52.2M-1.3%	$52.9M-2.9%	$54.4M-1.7%	$55.4M-31.9%	$81.3M+25.1%	$65.0M-2.7%	$66.8M-5.7%	$70.8M	N/A	N/A	N/A	N/A
Total Equity	$349K+112.0%	-$2.9M-1677.8%	$185K-95.0%	$3.7M-64.3%	$10.4M-6.4%	$11.1M-5.4%	$11.7M+90.9%	$6.2M-65.6%	$17.9M+147.1%	-$37.9M-59.2%	-$23.8M-508.9%	$5.8M-31.3%	$8.5M-46.6%	$15.9M-2.7%	$16.3M
Retained Earnings	-$81.8M+3.9%	-$85.1M-3.9%	-$81.9M+32.5%	-$121.4M-6.0%	-$114.5M-1.0%	-$113.4M-0.6%	-$112.7M+4.7%	-$118.2M-11.2%	-$106.3M-6.7%	-$99.6M-17.5%	-$84.8M-51.2%	-$56.1M-40.6%	-$39.9M-54.9%	-$25.8M-37.6%	-$18.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$68.0M+13.0%	$67.3M+13.5%	$67.8M+12.1%	$72.2M+20.1%	$60.1M-1.9%	$59.3M-3.2%	$60.5M-2.8%	$60.1M-6.2%
Current Assets	$17.7M	$16.2M	$16.3M+138.8%	N/A	N/A	N/A	$6.8M	N/A
Cash & Equivalents	$1.7M+325.0%	$1.1M+120.0%	$3.0M+415.5%	$1.0M+100.0%	$400K-42.9%	$500K-37.5%	$582K-41.8%	$500K-64.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.5M	$1.6M	$1.4M	$1.4M	N/A	N/A	N/A	N/A
Accounts Receivable	$10.3M+135.7%	$10.1M+176.3%	$8.0M+138.7%	$7.7M+279.3%	$4.4M+140.3%	$3.6M+148.6%	$3.4M+140.1%	$2.0M0.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%
Total Liabilities	$65.0M-0.9%	$63.6M+0.2%	$62.8M-1.0%	$69.0M+10.5%	$65.6M+4.6%	$63.4M+2.4%	$63.4M+2.2%	$62.4M-1.9%
Current Liabilities	$27.1M	$25.3M	$24.2M+18.4%	N/A	N/A	N/A	$20.4M	N/A
Non-Current Liabilities	$37.9M	$38.3M	$38.6M-10.1%	N/A	N/A	N/A	$43.0M	N/A
Long-Term Debt	$34.1M-30.2%	$34.5M-29.7%	$34.7M-11.6%	$48.6M-2.2%	$48.9M-2.6%	$49.2M-1.7%	$39.3M-22.6%	$49.7M-3.3%
Total Equity	-$1.7M+68.6%	-$962K+76.9%	$349K+112.0%	-$1.5M+35.4%	-$5.5M-284.9%	-$4.2M-466.6%	-$2.9M-1677.8%	-$2.4M-715.0%
Retained Earnings	-$83.7M+5.3%	-$82.9M+4.7%	-$81.8M+3.9%	-$84.8M-0.3%	-$88.4M-5.8%	-$87.0M-5.0%	-$85.1M-3.9%	-$84.6M-3.5%

RHEPA Cash Flow Statement

RHEPA quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$2.6M	-$2.3M-216.3%	$1.9M-47.7%	$3.7M+203.2%	-$3.6M-173.5%	$4.9M+277.9%	$1.3M-46.0%	$2.4M+77.7%	$1.3M-73.8%	$5.1M+250.9%	-$3.4M+80.9%	-$17.8M-190.2%	-$6.1M-221.2%	$5.1M+249.9%	$1.4M-27.4%	$2.0M
Depreciation & Amortization	N/A	$2.1M0.0%	$2.1M-8.6%	$2.3M-6.2%	$2.4M-7.2%	$2.6M-10.5%	$2.9M-15.8%	$3.4M-25.8%	$4.6M-4.8%	$4.9M-8.1%	$5.3M-27.9%	$7.3M-0.6%	$7.4M+6.9%	$6.9M+5.8%	$6.5M+94.6%	$3.4M
Stock-Based Compensation	N/A	$233K+104.4%	$114K-68.1%	$357K+53.2%	$233K-51.6%	$481K+881.6%	$49K-46.7%	$92K-47.7%	$176K-34.1%	$267K-76.4%	$1.1M+20.3%	$942K-18.4%	$1.2M+5.3%	$1.1M+23.1%	$891K+10.5%	$806K
Capital Expenditures	$1.4M	$869K+64.0%	$530K-44.7%	$958K+240.9%	$281K+128.5%	$123K-72.7%	$450K+675.9%	$58K-82.8%	$338K-60.0%	$846K-43.6%	$1.5M-16.6%	$1.8M-56.5%	$4.1M-8.4%	$4.5M-19.5%	$5.6M+32.3%	$4.2M
Free Cash Flow	-$3.9M	-$3.1M-321.4%	$1.4M-48.7%	$2.8M+171.0%	-$3.9M-181.3%	$4.8M+464.6%	$845K-63.9%	$2.3M+131.5%	$1.0M-76.5%	$4.3M+187.6%	-$4.9M+75.0%	-$19.6M-90.8%	-$10.3M-1992.1%	$543K+113.0%	-$4.2M-85.0%	-$2.3M
Investing Cash Flow	$14.6M	$15.1M+2949.4%	-$530K+44.7%	-$958K-240.9%	-$281K-128.5%	-$123K+72.7%	-$450K-111.8%	$3.8M+1230.5%	-$338K+85.1%	-$2.3M-109.4%	$24.1M+145.1%	$9.8M+8387.1%	$116K+103.7%	-$3.1M+94.7%	-$59.2M+3.0%	-$61.0M
Financing Cash Flow	-$10.7M	-$10.3M-382.4%	-$2.1M+14.3%	-$2.5M-20.2%	-$2.1M+14.6%	-$2.4M-73.6%	-$1.4M+70.2%	-$4.7M-4087.2%	$117K+100.7%	-$17.0M-81.2%	-$9.4M-17305.6%	-$54K+97.9%	-$2.6M-275.0%	$1.5M-97.7%	$66.5M+6.4%	$62.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$3.3M	$0	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	$46K+557.1%	$7K	N/A	N/A	N/A	$186K-64.4%	$523K	$0	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$1.4M+143.8%	-$890K-477.1%	-$1.3M-232.8%	-$1.8M-1506.3%	$569K+12.7%	$236K-60.5%	$953K+278.2%	-$112K-122.2%
Depreciation & Amortization	$757K+87.8%	$722K+79.6%	$712K+26.5%	$547K+15.4%	$403K-21.6%	$402K-21.3%	$563K+8.9%	$474K-9.9%
Stock-Based Compensation	$73K+192.0%	$96K+336.4%	N/A	N/A	$25K	$22K-48.8%	N/A	N/A
Capital Expenditures	$498K+68.8%	$364K+460.0%	$226K+126.0%	$283K+708.6%	$295K-13.2%	$65K+18.2%	$100K+138.1%	$35K-43.5%
Free Cash Flow	$889K+224.5%	-$1.3M-833.3%	-$1.5M-274.9%	-$2.1M-1316.3%	$274K+66.1%	$171K-68.5%	$853K+306.2%	-$147K-133.2%
Investing Cash Flow	-$498K-68.8%	-$364K-460.0%	$9.8M+9870.0%	$5.7M+16362.9%	-$295K+13.2%	-$65K-18.2%	-$100K-138.1%	-$35K+43.5%
Financing Cash Flow	-$388K-220.7%	-$735K-25.2%	-$6.4M-628.4%	-$3.1M-4246.7%	-$121K+78.6%	-$587K+21.8%	-$883K-33.6%	$75K+111.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

RHEPA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RHEPA quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	86.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	3.1%+2.3pp	0.9%+5.7pp	-4.8%+14.2pp	-19.0%-28.5pp	9.5%-3.6pp	13.1%-14.1pp	27.1%+30.7pp	-3.6%-24.0pp	20.4%+4.1pp	16.4%+57.9pp	-41.5%	-727.8%	-0.9%-2.3pp	1.4%+0.6pp	0.8%
Net Margin	6.3%+23.9pp	-17.5%+5.1pp	-22.7%-3.5pp	-19.1%-14.7pp	-4.4%-0.5pp	-3.9%-31.2pp	27.3%+81.3pp	-54.0%-50.0pp	-3.9%+23.1pp	-27.0%	-127.8%	-409.0%	-6.8%-3.2pp	-3.5%+0.9pp	-4.5%
Return on Equity	965.6%	N/A	-2101.6%-1916.8pp	-184.8%-173.4pp	-11.4%-5.2pp	-6.2%-53.0pp	46.8%+240.2pp	-193.4%-187.9pp	-5.5%	N/A	N/A	-233.3%-85.2pp	-148.1%-104.8pp	-43.3%-5.6pp	-37.7%
Return on Assets	5.0%+10.3pp	-5.3%+0.9pp	-6.3%+3.8pp	-10.0%-8.9pp	-1.1%-0.5pp	-0.6%-5.5pp	4.8%+16.7pp	-11.8%-10.9pp	-0.9%+5.3pp	-6.3%+7.6pp	-13.9%-7.4pp	-6.5%-0.9pp	-5.5%-2.6pp	-2.9%+0.9pp	-3.9%
Current Ratio	0.67+0.3x	0.33	N/A	N/A	N/A	N/A	0.52+0.3x	0.220.0x	0.24-0.6x	0.81+0.4x	0.39-0.4x	0.820.0x	0.85-0.1x	0.91+0.1x	0.84
Debt-to-Equity	99.54	N/A	274.24+260.2x	14.04+9.0x	5.09+0.2x	4.90+0.2x	4.71-8.5x	13.22+9.6x	3.64	N/A	N/A	31.94+8.5x	23.47+10.2x	13.28+4.5x	8.79
Asset Turnover	0.78+0.5x	0.300.0x	0.28-0.2x	0.52+0.3x	0.25+0.1x	0.160.0x	0.180.0x	0.220.0x	0.240.0x	0.23+0.1x	0.11+0.1x	0.02-0.8x	0.820.0x	0.820.0x	0.87
FCF Margin	-5.9%-13.6pp	7.7%-8.3pp	16.1%+26.8pp	-10.8%-28.7pp	17.9%+13.1pp	4.8%-6.8pp	11.6%+7.0pp	4.6%-12.5pp	17.1%+34.9pp	-17.8%	-106.5%	-309.0%	0.3%+2.4pp	-2.1%-0.5pp	-1.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	75.1%	78.8%	N/A	83.7%	N/A	N/A	N/A	N/A
Operating Margin	-0.9%+4.2pp	-3.3%+1.1pp	14.8%+5.3pp	-3.9%+3.2pp	-5.1%-10.0pp	-4.4%+2.7pp	9.6%+6.0pp	-7.1%+2.7pp
Net Margin	-3.2%+11.2pp	-5.8%+11.8pp	13.0%+23.0pp	22.3%+45.6pp	-14.4%+1.9pp	-17.5%+5.8pp	-10.0%-4.8pp	-23.2%+0.3pp
Return on Equity	N/A	N/A	773.4%	N/A	N/A	N/A	N/A	N/A
Return on Assets	-1.2%+1.3pp	-1.8%+0.3pp	4.0%+4.9pp	4.7%+6.3pp	-2.4%-1.3pp	-2.1%-0.6pp	-0.9%-0.6pp	-1.6%-0.1pp
Current Ratio	0.65	0.64	0.67+0.3x	N/A	N/A	N/A	0.33	N/A
Debt-to-Equity	N/A	N/A	99.54	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.36+0.2x	0.31+0.2x	0.31+0.2x	0.21+0.1x	0.17+0.1x	0.12+0.1x	0.090.0x	0.070.0x
FCF Margin	3.6%+0.9pp	-5.9%-8.3pp	-7.2%-22.3pp	-13.8%-10.3pp	2.7%-1.1pp	2.4%-10.8pp	15.1%+10.4pp	-3.5%-14.2pp

Note: The current ratio is below 1.0 (0.67), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
REGIONAL HEALTH PRP PFD A RHEPA	FY2025	$53.2M	$3.4M	6.3%	N/A	—
REGIONAL HLTH PPTY B PFD RHEPB	FY2025	$53.2M	$3.4M	6.3%	N/A	—
CARDIFF LEXINGTN CORP CDIX	FY2025	$11.5M	-$5.5M	-47.7%	$7.7M	—

Where REGIONAL HEALTH PRP PFD A Ranks

Frequently Asked Questions

What is REGIONAL HEALTH PRP PFD A's annual revenue?

REGIONAL HEALTH PRP PFD A (RHEPA) reported $53.2M in total revenue for fiscal year 2025. This represents a 189.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is REGIONAL HEALTH PRP PFD A's revenue growing?

REGIONAL HEALTH PRP PFD A (RHEPA) revenue grew by 189.9% year-over-year, from $18.3M to $53.2M in fiscal year 2025.

Is REGIONAL HEALTH PRP PFD A profitable?

Yes, REGIONAL HEALTH PRP PFD A (RHEPA) reported a net income of $3.4M in fiscal year 2025, with a net profit margin of 6.3%.

What is REGIONAL HEALTH PRP PFD A's EBITDA?

REGIONAL HEALTH PRP PFD A (RHEPA) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does REGIONAL HEALTH PRP PFD A have?

As of fiscal year 2025, REGIONAL HEALTH PRP PFD A (RHEPA) had $3.0M in cash and equivalents against $34.7M in long-term debt.

What is REGIONAL HEALTH PRP PFD A's gross margin?

REGIONAL HEALTH PRP PFD A (RHEPA) had a gross margin of 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is REGIONAL HEALTH PRP PFD A's operating margin?

REGIONAL HEALTH PRP PFD A (RHEPA) had an operating margin of 3.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is REGIONAL HEALTH PRP PFD A's net profit margin?

REGIONAL HEALTH PRP PFD A (RHEPA) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is REGIONAL HEALTH PRP PFD A's return on equity (ROE)?

REGIONAL HEALTH PRP PFD A (RHEPA) has a return on equity of 965.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is REGIONAL HEALTH PRP PFD A's free cash flow?

REGIONAL HEALTH PRP PFD A (RHEPA) recorded an outflow of $3.1M in free cash flow during fiscal year 2025. This represents a -321.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is REGIONAL HEALTH PRP PFD A's operating cash flow?

REGIONAL HEALTH PRP PFD A (RHEPA) recorded an outflow of $2.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are REGIONAL HEALTH PRP PFD A's total assets?

REGIONAL HEALTH PRP PFD A (RHEPA) had $67.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are REGIONAL HEALTH PRP PFD A's capital expenditures?

REGIONAL HEALTH PRP PFD A (RHEPA) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does REGIONAL HEALTH PRP PFD A have outstanding?

REGIONAL HEALTH PRP PFD A (RHEPA) had 4M shares outstanding as of fiscal year 2025.

What is REGIONAL HEALTH PRP PFD A's current ratio?

REGIONAL HEALTH PRP PFD A (RHEPA) had a current ratio of 0.67 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is REGIONAL HEALTH PRP PFD A's debt-to-equity ratio?

REGIONAL HEALTH PRP PFD A (RHEPA) had a debt-to-equity ratio of 99.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is REGIONAL HEALTH PRP PFD A's return on assets (ROA)?

REGIONAL HEALTH PRP PFD A (RHEPA) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does REGIONAL HEALTH PRP PFD A's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, REGIONAL HEALTH PRP PFD A (RHEPA) held $3.0M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.3M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is REGIONAL HEALTH PRP PFD A's Piotroski F-Score?

REGIONAL HEALTH PRP PFD A (RHEPA) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are REGIONAL HEALTH PRP PFD A's earnings high quality?

For every $1 of reported earnings, REGIONAL HEALTH PRP PFD A (RHEPA) used $0.67 of operating cash (-$2.3M OCF vs $3.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can REGIONAL HEALTH PRP PFD A cover its interest payments?

REGIONAL HEALTH PRP PFD A (RHEPA) has an interest coverage ratio of 0.62x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.